Measurement of liver iron content by magnetic resonance imaging in 20 patients with overt porphyria cutanea tarda before phlebotomy therapy: A prospective study

Acta Dermato-Venereologica

Volumn 88, Issue 4, 2008, Pages 341-345

  Dereure, Olivier ^a,b   Jumez, Nicolas ^a   Bessis, Didier ^a   Gallix, Benoit ^a   Guillot, Bernard ^a  

^a UNIV MONTPELLIER   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Liver iron content; Magnetic resonance imaging; Phlebotomies; Porphyria cutanea tarda

Indexed keywords

FERRITIN; IRON;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HEPATITIS C; HUMAN; IRON DEPLETION; LABORATORY TEST; MALE; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIODIAGNOSIS;

ADULT; FEMALE; FERRITINS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; PROSPECTIVE STUDIES;

EID: 47749092816     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0472     Document Type: Article

References (30)

1. Siersema PD, Rademakers LH, Cleton MI, ten Kate FJ, de Bruijn WC, Marx JJ, et al. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron. J Hepatol 1995; 23: 259-267.
2. D'Alessandro Gandolfo L, Griso D, Macri A, Biolcati G, Barlattani A, Topi GC. Iron and porphyria cutanea tarda. Cell Mol Biol (Noisy-le-grand) 1997; 43: 75-79.
3. O'Reilly FM, Darby C, Fogarty J, Tormey W, Kay EW, Leader M, Murphy GM. Screening of patients with iron overload to identify hemochromatosis and porphyria cutanea tarda. Arch Dermatol 1997; 133: 1098-1101.
4. Bygum A, Brandrup F. Iron overload in porphyria cutanea tarda. Br J Dermatol 2000; 143: 1116.
5. Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol 2003; 30: 137-144.
6. Bygum A, Christiansen L, Petersen NE, Horder M, Thomsen K, Brandrup F. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status. Acta Derm Venereol 2003; 83: 115-120.
7. Fargion S, Fracanzani AL, Romano R, Cappellini MD, Fare M, Mattioli M, et al. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload. J Hepatol 1996; 24: 564-569.
8. Mehrany K, Drage LA, Brandhagen DJ, Pittelkow MR. Association of porphyria cutanea tarda with hereditary hemochromatosis. J Am Acad Dermatol 2004; 51: 205-211.
9. Mukerji SK, Pimstone NR, Burns M. Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda. Gastroenterology 1984; 87: 1248-1254.
10. Menon IA, Becker MA, Haberman HF Role of iron in the photosensitization by uroporphyrin. Clin Chim Acta 1991; 202: 237-242.
11. Berlin SO, Brante GO. Iron metabolism in porphyria and haemochromatosis. Lancet 1962; 2 :729.
12. Lundvall O, Weinfeld A, Lundin P. Iron storage in porphyria cutanea tarda. Acta Med Scand 1970; 188: 37-53.
13. Lefkowitch JH, Grossman ME. Hepatic pathology in porphyria cutanea tarda. Liver 1983; 3: 19-29.
14. Kushner JP, Edwards CQ, Dadone MM, Skolnick MH. Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda. Gastroenterology 1985; 88: 1232-1238.
15. Siersema PD, Rademakers LH, Cleton MI, ten Kate FJ, de Bruijn WC, Marx JJ, et al. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron. J Hepatol 1995; 23: 259-267.
16. Elder GH. Porphyria cutanea tarda. Semin Liver Dis 1998; 18:67-75.
17. Sampietro M, Fiorelli G, Fargion S. Iron overload in porphyria cutanea tarda. Haematologica 1999; 84: 248-253.
18. Alla V, Bonkovsky HL. Iron in nonhemochromatotic liver disorders. Semin Liver Dis 2005; 25: 461-472.
19. Bulaj ZJ, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee DJ, et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000; 95: 1565-1571.
20. Dereure O, Aguilar-Martinez P, Bessis D, Perney P, Vallat C, Guillot B, et al. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France. Br J Dermatol 2001; 144: 533-539.
21. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, Sebille V, Deugnier Y. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357-362.
22. Carneiro AA, Fernandes JP, de Araujo DB, Elias J Jr, Martinelli AL, Covas DT, et al. Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry. Magn Reson Med 2005; 54: 122-128.
23. St Pierre TG, Clark PR, Chua-Anusorn W. Measurement and mapping of liver iron concentrations using magnetic resonance imaging. Ann N Y Acad Sci 2005; 1054: 379-385.
24. Papakonstantinou OG, Maris TG, Kostaridou V, Gouliamos AD, Koutoulas GK, Kalovidouris AE, et al. Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMR1 measurements with serum ferritin concentration and histologic grading of siderosis. Magn Reson Imaging 1995; 13: 967-977.
25. Rocchi E, Cassanelli M, Borghi A, Paolillo F, Pradelli M, Pellizzardi S, et al. Liver iron overload and desferrioxamine treatment of porphyria cutanea tarda. Dermatologica 1991; 182:27-31.
26. Rocchi E, Cassanelli M, Borghi A, Paolillo F, Pradelli M, Casalgrandi G, et al. Magnetic resonance imaging and different levels of iron overload in chronic liver disease. Hepatology 1993; 17: 997-1002.
27. Rocchi E, Gibertini P, Cassanelli M, Pietrangelo A, Borghi A, Ventura E. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda. J Lab Clin Med 1986; 107: 36-42.
28. Gibertini P, Rocchi E, Cassanelli M, Pietrangelo A, Coppini M, Ventura E. Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis. Minerva Med 1984; 75: 469-474.
29. Lundvall O. The effect of phlebotomy therapy in porphyria cutanea tarda. Acta Med Scand 1971; 189: 33-49.
30. Détivaud L, Nemeth E, Boudjema K, Turlin B, Troadec MG, Leroyer, et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels and hepatic function. Blood 2005; 106:746-748.